Effects of lidocaine administered through tracheal tube drug spray ports on cough suppression during emergence and extubation after general anesthesia

Status

Unknown

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230112001

Enrollment

Registered

2023-01-12

Start date

2023-01-12

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of lidocaine administered through tracheal tube drug spray ports on cough suppression during emergence and extubation after general anesthesia Lidocaine Tracheal tube spray ports Cough suppression Emergence extubation

Interventions

Lidocaine spray via upper endotracheal tube cuff port

Experimental Drug

Lidocaine group

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adult Supine position ASA 1-3 Elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: GERD predicted difficult airway Lidocaine allergy URI symptom

Design outcomes

Primary

Measure	Time frame
Cough suppression 24 hours Cough severity	—

Secondary

Measure	Time frame
Sorethroat 24 hours Yes/no	—

Countries

Thailand

Contacts

Public ContactMunta Parinyathanakul

Faculty of medicine ramathibodi hospital,Mahidol university

Muntarr13@gmail.com0851565179

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026